210 related articles for article (PubMed ID: 28258962)
21. Pulmonary metastasectomy from renal cell carcinoma including 3 cases with sarcomatoid component.
Ueno T; Yamashita M; Sawada S; Sugimoto R; Nishijima N; Sugawara Y; Ninomiya I
Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):149-52. PubMed ID: 26809845
[TBL] [Abstract][Full Text] [Related]
22. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
23. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT.
Brufau BP; Cerqueda CS; Villalba LB; Izquierdo RS; González BM; Molina CN
Radiographics; 2013 Oct; 33(6):1691-716. PubMed ID: 24108558
[TBL] [Abstract][Full Text] [Related]
24. Risk of subsequent cancers in renal cell carcinoma survivors with a family history.
Chen T; Fallah M; Sundquist K; Liu H; Hemminki K
Eur J Cancer; 2014 Aug; 50(12):2108-18. PubMed ID: 24923229
[TBL] [Abstract][Full Text] [Related]
25. Renal Cell Carcinoma: Delayed Metachronous Metastases to Parotid and Cerebellum.
Kolokythas A; Weiskopf S; Singh M; Cabay RJ
J Oral Maxillofac Surg; 2015 Jul; 73(7):1296-303. PubMed ID: 25925095
[TBL] [Abstract][Full Text] [Related]
26. Successful Therapy with Nivolumab in Metastatic Renal Cell Carcinoma After Multiple Prior Treatments.
Finelli NC; Baig SA; Masters GA
Del Med J; 2017 Jan; 89(1):14-17. PubMed ID: 29714832
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatments for multiple primary adenocarcinoma of the lung.
Nakata M; Sawada S; Yamashita M; Saeki H; Kurita A; Takashima S; Tanemoto K
Ann Thorac Surg; 2004 Oct; 78(4):1194-9. PubMed ID: 15464469
[TBL] [Abstract][Full Text] [Related]
28. Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.
Colomba E; Le Teuff G; Eisen T; Stewart GD; Fife K; Larkin J; Biondo A; Pickering L; Srinivasan A; Boyle H; Derosa L; Sternberg CN; Recine F; Ralph C; Saldana C; Barthélémy P; Bernhard JC; Gurney H; Verhoest G; Vauleon E; Bigot P; Berger J; Pfister C; Gravis G; Rodier JM; Culine S; Caty A; Rolland F; Priou F; Escudier B; Albiges L
Eur J Cancer; 2017 Jul; 80():55-62. PubMed ID: 28549248
[TBL] [Abstract][Full Text] [Related]
29. Incidence and prognostic significance of second primary cancers in renal cell carcinoma.
Chakraborty S; Tarantolo SR; Batra SK; Hauke RJ
Am J Clin Oncol; 2013 Apr; 36(2):132-42. PubMed ID: 22441339
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of metastatic renal cell carcinoma on fine-needle aspiration cytology.
Lew M; Foo WC; Roh MH
Arch Pathol Lab Med; 2014 Oct; 138(10):1278-85. PubMed ID: 25268189
[TBL] [Abstract][Full Text] [Related]
31. Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report.
Noguchi G; Tsutsumi S; Yasui M; Ohtake S; Umemoto S; Nakaigawa N; Yao M; Kishida T
BMC Urol; 2018 Apr; 18(1):26. PubMed ID: 29669553
[TBL] [Abstract][Full Text] [Related]
32. Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors.
Hayes TG; Falchook GS; Varadhachary A
Invest New Drugs; 2010 Apr; 28(2):156-62. PubMed ID: 19238327
[TBL] [Abstract][Full Text] [Related]
33. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years.
Johnson BE; Linnoila RI; Williams JP; Venzon DJ; Okunieff P; Anderson GB; Richardson GE
J Clin Oncol; 1995 Jan; 13(1):101-11. PubMed ID: 7799009
[TBL] [Abstract][Full Text] [Related]
34. Basaloid squamous carcinoma metastatic to renal-cell carcinoma: fine-needle aspiration cytology of tumor-to-tumor metastasis.
Khurana KK; Powers CN
Diagn Cytopathol; 1997 Nov; 17(5):379-82. PubMed ID: 9360052
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.
Korst RJ; Kansler AL; Port JL; Lee PC; Altorki NK
Ann Thorac Surg; 2006 Sep; 82(3):1009-15; discussion 1015. PubMed ID: 16928526
[TBL] [Abstract][Full Text] [Related]
36. Commentary on "Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α." Tsimafeyeu I, Zart JS, Chung B, Kidney Cancer Research Bureau, Moscow, Russian Federation.: BJU Int 2013; 112(1):32-8. [Epub 2013 Jun 7]. doi: 10.1111/bju.12107.
Boorjian S
Urol Oncol; 2014 May; 32(4):514-5. PubMed ID: 24767689
[TBL] [Abstract][Full Text] [Related]
37. Lung cancer as a second primary malignancy: increasing prevalence and its influence on survival.
Quadrelli S; Lyons G; Colt H; Chimondeguy D; Silva C
Ann Surg Oncol; 2009 Apr; 16(4):1033-8. PubMed ID: 19190966
[TBL] [Abstract][Full Text] [Related]
38. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
Sacher AG; Le LW; Lau A; Earle CC; Leighl NB
Cancer; 2015 Aug; 121(15):2562-9. PubMed ID: 25891153
[TBL] [Abstract][Full Text] [Related]
39. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis.
Vera-Badillo FE; Templeton AJ; Duran I; Ocana A; de Gouveia P; Aneja P; Knox JJ; Tannock IF; Escudier B; Amir E
Eur Urol; 2015 Apr; 67(4):740-9. PubMed ID: 24882670
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma.
Ueda K; Suekane S; Kurose H; Chikui K; Nakiri M; Nishihara K; Matsuo M; Kawahara A; Yano H; Igawa T
Urol Oncol; 2018 Nov; 36(11):499.e9-499.e16. PubMed ID: 30131293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
